Strategic Science

Strategic Science & Technologies (SST) is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, specializing in the development of topical formulations for proven pharmaceutical ingredients. The company's core innovation is a proprietary transdermal delivery platform designed to provide localized therapeutic effects while minimizing systemic exposure and associated side effects. SST's most advanced programs involve topical sildenafil for the treatment of Female Sexual Arousal Disorder (FSAD) and Erectile Dysfunction (ED). Through strategic partnerships, such as its licensing agreement with Daré Bioscience, SST continues to advance its pipeline toward commercialization. The company also explores applications for its delivery technology in pain management and other therapeutic areas.